Literature DB >> 6305277

Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity.

P L Gutiérrez, M V Gee, N R Bachur.   

Abstract

Adriamycin free radical anion concentrations have been correlated with production of 7-deoxyadriamycin aglycone in a reaction catalyzed by NADPH-cytochrome c reductase. The free radical species is detected by electron spin resonance (ESR) spectroscopy and quantified by double integrations. The 7-deoxyaglycone product is isolated by thin-layer chromatography (TLC) and quantified by fluorometry. As the concentration of adriamycin increases, a concomitant increase in aglycone and free radical levels occurs. These results as well as those with inhibitors Vitamin K3, Vitamin E, and 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) point to an obligatory free radical intermediate in the metabolism of adriamycin. DMPO inhibits the reaction under aerobic conditions only, and shows no effect under anaerobiosis at the concentrations studied here. Vitamin E and aerobic DMPO act as free radical scavangers, while Vitamin K3 competes for the reducing power of NADPH in the NADPH-cytochrome c reductase system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305277     DOI: 10.1016/0003-9861(83)90572-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Influence of ubiquinone on the inhibitory effect of adriamycin on mitochondrial oxidative phosphorylation.

Authors:  H Muhammed; C K Kurup
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

2.  Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide.

Authors:  Christopher Horst Lillig; Maria Elisabet Lönn; Mari Enoksson; Aristi Potamitou Fernandes; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

3.  Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells.

Authors:  P F Lenehan; P L Gutiérrez; J L Wagner; N Milak; G R Fisher; D D Ross
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Improved immunocytochemical detection of daunomycin.

Authors:  Koji Ohara; Masashi Shin; Lars-Inge Larsson; Kunio Fujiwara
Journal:  Histochem Cell Biol       Date:  2007-01-25       Impact factor: 2.531

Review 5.  A chemical perspective on the anthracycline antitumor antibiotics.

Authors:  B R Abdella; J Fisher
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

6.  An evaluation of hepatic extraction and clearance of doxorubicin.

Authors:  D A August; N Verma; M A Vaertan; R Shah; D E Brenner
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

Review 7.  Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?

Authors:  Balaraman Kalyanaraman
Journal:  Redox Biol       Date:  2019-11-26       Impact factor: 11.799

8.  A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets.

Authors:  Matthew Ryan Smith; Balu K Chacko; Michelle S Johnson; Gloria A Benavides; Karan Uppal; Young-Mi Go; Dean P Jones; Victor M Darley-Usmar
Journal:  Redox Biol       Date:  2019-09-07       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.